The CASTRO Study: Unsafe Sexual Behaviors and Illicit Drug Use Among Gay and Bisexual Men Who Use Anabolic Steroids
Overview
Authors
Affiliations
Background And Objectives: The majority of anabolic androgenic steroid (AAS) studies have focused on the general male population. Approximately 15% of gay or bisexual men are seropositive for HIV and many AASs are administered via injection. Thus, AAS use among gay and bisexual men likely poses a greater risk of spreading infectious disease. Gay and bisexual men who use AAS were compared with non-users regarding self-reported seropositivity for HIV and hepatitis B and C, sexual behaviors and injection practices, illicit drug and alcohol use, and psychiatric disorders.
Methods: The CASTRO (Castro Anabolic Steroid Research Observation) study was a 108-item cross-sectional survey of 153 gay and bisexual men who exercise. Data collection occurred outside four gyms in the San Francisco Castro District.
Results: The lifetime prevalence of AAS use among gay and bisexual men in the study was 21.6%. AAS users and non-users did not differ in self-reported seropositivity for HIV or hepatitis B and C, but AAS users reported higher rates of male-male condomless anal sex in the past year (84.8 vs 60.8%, p < .01) than non-users. More AAS users used ecstasy and methamphetamines (39.4 vs 16.7%, p < .01 and 18.2 vs 5.0%, p = .01, respectively) than non-users.
Discussion And Conclusions: Gay and bisexual men who used AAS were more likely to engage in unsafe sexual behaviors and use illicit drugs relative to non-users. Multiple factors place AAS users at higher risks for spreading infectious diseases.
Scientific Significant: Our study suggests increased infectious disease risk among gay and bisexual men who use AAS. (Am J Addict 2019;XX:1-10).
Kutscher E, Arshed A, Greene R, Kladney M Harm Reduct J. 2024; 21(1):196.
PMID: 39523302 PMC: 11552109. DOI: 10.1186/s12954-024-01121-8.
Exploring Anabolic Androgenic Steroid Use Among Cisgender Gay, Bisexual, and Queer Men.
Kutscher E, Arshed A, Greene R, Kladney M JAMA Netw Open. 2024; 7(5):e2411088.
PMID: 38743422 PMC: 11094559. DOI: 10.1001/jamanetworkopen.2024.11088.
The sexual impact of androgenic anabolic steroid abuse an understudied phenomena.
Akula K, McBeth L, Hofer M Int J Impot Res. 2024; 37(2):114-115.
PMID: 38594389 DOI: 10.1038/s41443-024-00879-6.
Chan M, Liu S, White B, Zhang A, Zhou Y, Leung M J Consult Clin Psychol. 2023; 91(10):574-595.
PMID: 37410398 PMC: 10527151. DOI: 10.1037/ccp0000827.
Star J Can J Public Health. 2022; 114(2):308-316.
PMID: 36068433 PMC: 9447957. DOI: 10.17269/s41997-022-00683-z.